Position | Description |
---|---|
245 | Not glycosylated |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
55 | N-linked (GlcNAc...) asparagine |
|
||
93 | N-linked (GlcNAc...) asparagine | |||
139 |
|
|
||
197 |
|
|||
221 | N-linked (GlcNAc...) asparagine |
|
||
245 | N-linked (GlcNAc...) asparagine |
|
||
320 |
|
|||
329 |
|
|||
335 |
|
|||
350 | N-linked (GlcNAc...) asparagine |
|
Pathway Name | Organism |
---|---|
Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
Interleukin-6 signaling | Homo sapiens |
MAPK1 (ERK2) activation | Homo sapiens |
MAPK3 (ERK1) activation | Homo sapiens |
Potential therapeutics for SARS | Homo sapiens |
Transcriptional regulation of granulopoiesis | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0080545 | hyper IgE syndrome | |
DOID:10534 | stomach cancer | |
DOID:10652 | Alzheimer's disease | |
DOID:12858 | Huntington's disease | |
DOID:9970 | obesity |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025